Cyclin E expression was examined by Western blotting in
tumor tissue samples from 130 potentially resected
rectal cancer patients with pathological stages I- III. Blood vessel invasion (BVI) was detected by immunohistochemistry. Multivariate analysis using the COX proportional hazards models was applied to evaluate the independent prognostic
tumor markers of
rectal cancer.
RESULTS: The high expression rate of
cyclin E in rectal
carcinoma tissue was 23.1%(30/130). Except for a positive correlation with BVI and the gross configuration of
tumor, the expression of
cyclin E showed no significant relation to other clinicopathological factors. The 5-year disease-specific survival rate of
cyclin E high expression group was 29.2%, which was significantly lower as compared to that of
cyclin low expression group 70.5% (P<0.05). Multivariate analysis revealed that histology and
cyclin E expression were independent prognostic indicators for
rectal cancer patients at stages I- III. Compared to those with low expression levels, patients with high
cyclin E levels had the hazard ratio (95%CI) for death from
rectal cancer for 3.544 (1.528-8.215). In stage I- II, multivariate analysis showed that stronger predictive values of
cyclin E expression even were detected. Patients with low
cyclin E expression and negative BVI had a significantly better prognosis than those with high
cyclin E expression and positive BVI.
CONCLUSIONS: The expression of
cyclin E is independent prognostic factor in rectal
carcinoma at stages I- III. Detecting the expression of
cyclin E and/or combined with BVI may help to predict clinical outcome and design further individualized intensive adjuvant treatment.